Miv Therapeutics
Miv Therapeutics is a Private Indian company incorporated in 2003 and based in Gujarat, India. Miv Therapeutics operates in Medical & Precision (NIC 33112) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
MIV Therapeutics - Develops devices for coronary and peripheral vascular procedures. Acquired by Purple Medical Solution.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Miv Therapeutics.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +31d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +10d | filed |
| MGT-7 | FY2023-24 | 22 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Miv Therapeutics.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 804246591 | Kotak Mahindra Bank Ltd(Bank) | ₹14.84 Cr | 04 Jul 2022 | Open |
| 335122235 | Axis Bank Ltd(Bank) | ₹21.30 Cr | 27 Jan 2020 | Open |
| 571455041 | HDFC Bank Ltd(Bank) | ₹7.61 Cr | 27 Jan 2021 | Open |
| 549301918 | Kotak Mahindra Bank Ltd(Bank) | ₹20.84 Cr | 19 Sep 2021 | Open |
Charge IDs, lenders & amounts for Miv Therapeutics.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹17.65 Cr | ₹-83.00 L | ₹13.87 Cr | ₹20.98 Cr | 141 |
| FY2023-24 | ₹14.83 Cr | ₹-67.85 L | ₹10.93 Cr | ₹18.42 Cr | 335 |
| FY2022-23 | ₹11.92 Cr | ₹-29.27 L | ₹7.18 Cr | ₹13.46 Cr | 168 |
| FY2021-22 | ₹12.59 Cr | ₹-48.15 L | ₹8.49 Cr | ₹18.03 Cr | 128 |
Audited financials & ratios for Miv Therapeutics.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹17.65 Cr | ₹14.83 Cr | ₹11.92 Cr | ₹12.59 Cr |
| Other income | ₹41.02 L | ₹33.16 L | ₹20.95 L | ₹37.28 L |
| Total income | ₹18.06 Cr | ₹15.16 Cr | ₹12.13 Cr | ₹12.96 Cr |
| Total expenses | ₹19.13 Cr | ₹16.03 Cr | ₹12.51 Cr | ₹13.58 Cr |
| Profit before tax | ₹-1.08 Cr | ₹-88.20 L | ₹-38.05 L | ₹-62.59 L |
| Profit / (Loss) after tax | ₹-83.00 L | ₹-67.85 L | ₹-29.27 L | ₹-48.15 L |
| Balance sheet | ||||
| Equity / Net worth | ₹13.87 Cr | ₹10.93 Cr | ₹7.18 Cr | ₹8.49 Cr |
| Borrowings | ₹3.03 Cr | ₹2.66 Cr | ₹1.80 Cr | ₹3.96 Cr |
| Current liabilities | ₹3.54 Cr | ₹2.65 Cr | ₹3.14 Cr | ₹3.53 Cr |
| Total liabilities | ₹7.11 Cr | ₹7.49 Cr | ₹6.29 Cr | ₹9.54 Cr |
| Current assets | ₹11.89 Cr | ₹10.90 Cr | ₹5.89 Cr | ₹10.45 Cr |
| Cash & equivalents | ₹1.59 Cr | ₹3.14 Cr | ₹1.79 Cr | ₹2.25 Cr |
| Total assets | ₹20.98 Cr | ₹18.42 Cr | ₹13.46 Cr | ₹18.03 Cr |
| Employees | 141 | 335 | 168 | 128 |
Audited financials & ratios for Miv Therapeutics.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹17.65 Cr | -4.6% | +18.9% | +9.3% |
| Profit after Tax | ₹-83.00 L | +19.2% | +4.5% | +17.6% |
| Net Worth | ₹13.87 Cr | +14.8% | +16.8% | +3.6% |
| Employees | 141 | +0.8% | +10.2% | +13.3% |
Audited financials & ratios for Miv Therapeutics.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹17.65 Cr | ₹-83.00 L | -4.70% | -3.26% | -5.98% | -3.96% | 0.22 | ₹12.52 L |
| FY2023-24 | ₹14.83 Cr | ₹-67.85 L | -4.57% | +29.00% | -6.21% | -3.68% | 0.24 | ₹4.43 L |
| FY2022-23 | ₹11.92 Cr | ₹-29.27 L | -2.45% | -14.06% | -4.08% | -2.17% | 0.25 | ₹7.10 L |
| FY2021-22 | ₹12.59 Cr | ₹-48.15 L | -3.83% | +24.77% | -5.67% | -2.67% | 0.47 | ₹9.83 L |
Audited financials & ratios for Miv Therapeutics.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 2,35,29,766 | 65.00% |
| Institutional Investors | 2 | 59,70,794 | 16.49% |
| Public & Others | 63 | 67,01,510 | 18.51% |
Promoter, institutional & public holding for Miv Therapeutics.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
3 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.